( g ) Degree of mitochondrial outer membrane permeabilization (% MOMP) in HCT116 cells 5FU when treated with compounds as indicated
No equivalent application has been publicly confirmed with the UKs Medicines and Healthcare products Regulatory Agency (MHRA), so it isnt yet available in the UK
doi: 10.1186/s10020-022-00574-6 88 Moschovaki FilippidouFKirschAHThelenMKtszeriMArtingerKAringerIet al
Researchers also evaluated tirzepatide drugs, including Mounjaro and Zepbound
Science: ZeroHarm Sciences' brand name, "Zero Harm," and its promise of "no side effects" are central to its identity
Trnka D, Engelke AD, Gellert M, Moseler A, Hossain MF, Lindenberg TT, et al